Welcome to our dedicated page for Amedisys news (Ticker: AMED), a resource for investors and traders seeking the latest updates and insights on Amedisys stock.
Amedisys, Inc. (NASDAQ: AMED) is a healthcare at home company that reports on developments across home health, hospice and high acuity care services delivered in the home. The Amedisys news flow includes regular earnings announcements, corporate updates and clinical program disclosures that reflect its role in the home health care services industry.
Investors and observers following AMED news can expect detailed quarterly and annual financial results, including net service revenue, net income, adjusted EBITDA and other non-GAAP measures that Amedisys reconciles to GAAP in its releases. These earnings communications often discuss factors such as merger-related expenses, impairment charges and other items that affect reported and adjusted results.
Amedisys also issues news about its clinical initiatives and partnerships. For example, the company has announced the rollout of advanced molecular testing for infection diagnosis in collaboration with Patient Choice Laboratories, aimed at improving the speed and accuracy of identifying pathogens in urine, respiratory and wound infections in the home setting. Through its subsidiary Contessa Health, Amedisys has highlighted participation in models such as the Centers for Medicare & Medicaid Services’ GUIDE Model for dementia care, reflecting activity in alternative payment and care delivery models.
Other Amedisys news items cover recognition for patient and caregiver satisfaction, such as SHPBest™ awards for home health and hospice care centers, and updates related to its merger with UnitedHealth Group, including regulatory and legal milestones. Readers who monitor AMED news gain insight into the company’s financial performance, regulatory environment, care quality indicators and the evolution of its home-based service offerings.
Amedisys, a top provider of home health services, announced its participation in the Stephens Annual Investment Conference on December 3rd at 10:00 AM Eastern. Presenters include Paul B. Kusserow, CEO, Chris Gerard, COO, and Scott Ginn, CFO. The event can be accessed via a live webcast on Amedisys' investor relations website. With over 21,000 employees and 529 care centers nationwide, Amedisys delivers personalized care to over 418,000 patients annually, partnering with more than 2,900 hospitals and 78,000 physicians across the U.S.
Penn State Health has formed a partnership with Highmark Health and Contessa to introduce Home Recovery Care, which includes Hospital and Skilled Nursing Care at Home. This initiative aims to provide essential hospital-level care in patients' homes, enhancing patient comfort while potentially reducing healthcare costs. The model, which has shown a 44% reduction in readmissions and a 35% decrease in hospital stay length, is set to launch at the Milton S. Hershey Medical Center in the first half of 2022, initially for Highmark Medicare Advantage members.
Amedisys, a top provider of home health and hospice services, announced its participation in the Jefferies London Healthcare Conference on November 18, 2021, at 3:00 PM Eastern. Presenters include CEO Paul B. Kusserow, COO Chris Gerard, and CFO Scott Ginn. A live webcast of the presentation will be accessible on their website. Amedisys specializes in personalized home care, catering to patients recovering from surgeries, managing chronic illnesses, and providing hospice care. The company serves over 418,000 patients annually through its extensive network of care centers across the U.S.
Amedisys reported financial results for Q3 2021, with net service revenue rising to $553.5 million, up from $544.1 million in 2020. However, net income dropped to $45.0 million, down from $72.0 million in the previous year. Adjusted EBITDA for the quarter was $72.4 million, a decrease from $75.7 million in 2020. For the nine-month period, net service revenue increased by $134.0 million to $1,654.8 million. The company adjusted its 2021 guidance, expecting net service revenue between $2.200 billion and $2.205 billion.
Amedisys, Inc. (NASDAQ: AMED) announced that its leadership team, including CEO Paul B. Kusserow, President Chris Gerard, and CFO Scott Ginn, will present at the Credit Suisse 30th Annual Virtual Healthcare Conference on November 9 at 12:10 p.m. Eastern.
Investors can access the live webcast via the company's investor relations website. Amedisys specializes in home health, hospice, personal care, and higher acuity services, serving over 418,000 patients annually across 38 states with a workforce of approximately 21,000 employees.
Amedisys, Inc. (NASDAQ: AMED) announced the acquisition of regulatory assets enabling the establishment of home health care centers in Charlotte and Raleigh, N.C. This expansion allows Amedisys to provide services to over 350,000 Medicare enrollees and 100,000 Medicare Advantage enrollees. The company will launch two new care centers in these markets, enhancing access to compassionate, high-quality care. Amedisys, a major provider in home health and hospice care in the U.S., operates 527 locations across 39 states.
Amedisys, Inc. (NASDAQ: AMED) will report its third quarter results for the period ending September 30, 2021, after market hours on November 2, 2021. An investor conference call to discuss these results is scheduled for November 3, 2021, at 11:00 a.m. ET. Participants can join the call by dialing (877) 524-8416 or (412) 902-1028. A replay will be available until December 3, 2021, via the same numbers. A live webcast will be accessible on Amedisys' Investor Relations website.
Henry Ford Health System has partnered with Contessa, an Amedisys company (NASDAQ: AMED), to introduce high-acuity home care services in Michigan. The new offerings include Hospital Care at Home, Skilled Nursing Care at Home, and Palliative Care at Home, aimed at delivering comprehensive patient care in a familiar environment. This initiative is expected to lower costs and improve patient outcomes, reducing readmission rates by 44% and hospital stays by 35%. Services will commence in December 2021 at Henry Ford Hospital in Detroit, with plans for future expansions.
Amedisys, Inc. (NASDAQ: AMED) announced on September 20, 2021, its definitive agreement to acquire regulatory assets enabling it to establish home health care centers in the Charlotte and Raleigh markets of North Carolina. The transaction, set to close on October 18, 2021, will allow Amedisys to expand its certified home health care services in Mecklenburg and Wake Counties, serving over 350,000 Medicare enrollees. This acquisition positions Amedisys to enhance its service area and patient care.
Amedisys, Inc. (NASDAQ: AMED) reported strong financial results for Q2 2021, achieving a net service revenue of $564.2 million, a significant increase from $485.0 million in 2020. Net income rose to $80.1 million compared to $34.7 million in the previous year. The company also announced the successful acquisition of Contessa Health, enhancing its home-based care delivery capabilities. Despite a solid performance, the Hospice segment faced challenges due to hiring difficulties. Updated guidance anticipates adjusted net service revenue between $2.241 billion and $2.259 billion for 2021.